. (2014). Ascertainment of acute liver injury in two European primary care databases. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1721-y
R. Schlienger
First name
R.
Last name
Schlienger
. (2016). Prevalence of antibiotic use: a comparison across various European health care data sources. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3831
. (2016). Impact of varying outcomes and definitions of suicidality on the associations of antiepileptic drugs and suicidality: comparisons from UK Clinical Practice Research Datalink (CPRD) and Danish national registries (DNR). Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3928
. (2016). A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-016-2071-8
. (2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3816
. (2017). Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12951
. (2019). Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study. Endocrinol Diabetes Metab. http://doi.org/10.1002/edm2.52
. (2019). Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study. Endocrinol Diabetes Metab. http://doi.org/10.1002/edm2.84